18/01/2024
Trifarotene reduces risk for atrophic acne scars
Dr Annika Smith, consultant dermatologist at several private clinics, including Melanoma Institute Australia and Mater Hospital Foundation says "it is the most recent topical retinoid to receive regulatory approval for the treatment of acne. Of note, it has very low systemic absorption, making it well-suited for the treatment of large skin areas.
In this study, trifarotene was effective and well tolerated in treating moderate-to-severe facial acne and reducing atrophic acne scars, with a reduction of total atrophic scar counts as early as week 2.
This topical agent promises to be a valuable adjunct to the acne treatment space, not only treating acne but addressing acne sequelae."
Acne Research Review Issue 3 - https://www.researchreview.com.au/au/Clinical-Area/General-Medicine/Dermatology/Acne/Acne-Research-Review,-Issue-3.aspx